Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Coenen

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Hepatology|December 17, 2011
The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patientsHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|May 5, 2021
Safety and Suitability of the SmartPill® after Abdominal Surgery: Results of the Prospective, Two-Armed, Open-Label PIDuSA TrialCornelius J van Beekum, Anke Esmann, Franziska Heinze, et al.
Gut Microbes|April 24, 2026
Calorie-restricted oat diet is associated with zonulin and short-chain fatty acid response in metabolic syndrome: a randomized controlled trialLinda Klümpen, Aakash Mantri, Anna Donkers, et al.
Kidney International|September 5, 2021
Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluriaBernd Hoppe, Annelize Koch, Pierre Cochat, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 12, 2023
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary SyndromesMichael Böttcher, Hans-Dirk Düngen, Vasile Corcea, et al.
Plos One|November 17, 2011
The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosisHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 15, 2008
Closed loop stimulation and accelerometer-based rate adaptation: results of the PROVIDE studyMartin Coenen, Klaus Malinowski, Wilhelm Spitzer, et al.
European Journal of Clinical Pharmacology|January 9, 2017
Who is a 'healthy subject'?-consensus results on pivotal eligibility criteria for clinical trialsKerstin Breithaupt-Groegler, Christoph Coch, Martin Coenen, et al.
European Journal of Immunology|October 16, 2009
Regulation of NK cell trafficking by CD81Benjamin Krämer, Daniela Schulte, Christian Körner, et al.
Clinical Drug Investigation|March 10, 2026
Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert PanelKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Hepatology|December 17, 2011
The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patientsHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|May 5, 2021
Safety and Suitability of the SmartPill® after Abdominal Surgery: Results of the Prospective, Two-Armed, Open-Label PIDuSA TrialCornelius J van Beekum, Anke Esmann, Franziska Heinze, et al.
Gut Microbes|April 24, 2026
Calorie-restricted oat diet is associated with zonulin and short-chain fatty acid response in metabolic syndrome: a randomized controlled trialLinda Klümpen, Aakash Mantri, Anna Donkers, et al.
Kidney International|September 5, 2021
Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluriaBernd Hoppe, Annelize Koch, Pierre Cochat, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 12, 2023
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary SyndromesMichael Böttcher, Hans-Dirk Düngen, Vasile Corcea, et al.
Plos One|November 17, 2011
The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosisHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 15, 2008
Closed loop stimulation and accelerometer-based rate adaptation: results of the PROVIDE studyMartin Coenen, Klaus Malinowski, Wilhelm Spitzer, et al.
European Journal of Clinical Pharmacology|January 9, 2017
Who is a 'healthy subject'?-consensus results on pivotal eligibility criteria for clinical trialsKerstin Breithaupt-Groegler, Christoph Coch, Martin Coenen, et al.
European Journal of Immunology|October 16, 2009
Regulation of NK cell trafficking by CD81Benjamin Krämer, Daniela Schulte, Christian Körner, et al.
Clinical Drug Investigation|March 10, 2026
Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert PanelKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.
Pageof 6